Clinical Trial Update: Multi-Arm Study to Test the Efficacy of Immunotherapeutic Agents in Multiple Sarcoma Subtypes [Phase 2]

View source ↗

Summary

Phase 2 multi-arm trial evaluating immunotherapeutic agents in multiple sarcoma subtypes has completed and results were posted on 2025-06-12.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced and/or Metastatic Sarcoma | Phase 2 | Status: COMPLETED | Results posted: 2025-06-12